Canaccord raised the firm’s price target on Docebo (DCBO) to $46 from $43 and keeps a Buy rating on the shares. The firm said they reported an excellent quarter with better-than-expected Q2 results and Q3 guidance. With more confidence on the macro after tariff induced uncertainty, albeit still with caution amid longer sales cycles and deal scrutiny, management also bumped its full year guidance.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCBO:
